Get the Stockscreener App
25.60
0.76%
-0.29
Schrodinger Inc stock is traded at $25.60, with a volume of 356.64K.
It is down -0.76% in the last 24 hours and up +21.48% over the past month.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$25.89
Open:
$25.93
24h Volume:
356.64K
Relative Volume:
0.44
Market Cap:
$1.89B
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-10.45
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
+2.47%
1M Performance:
+21.48%
6M Performance:
+42.35%
1Y Performance:
-2.82%
1-Day Range:
$25.40
$27.00
1-Week Range:
$23.57
$27.00
52-Week Range:
$16.67
$33.63
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
25.59 | 1.89B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
236.46 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.30 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
79.08 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
68.33 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.30 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Schrodinger Inc (SDGR) Shares Up 4.21% on Feb 5 - GuruFocus.com
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Top 5 AI & Digital Biotech Companies (February 2025) - Securities.io
Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance
First Week of February 21st Options Trading For Schrodinger (SDGR) - Nasdaq
Schrodinger Inc to Host Earnings Call - ACCESS Newswire
Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI - Insider Monkey
Schrodinger (SDGR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
10 AI News And Ratings on Wall Street’s Radar - Insider Monkey
Schrödinger Adopts the Sapio Platform to Enhance In Silico Drug Discovery - Contract Pharma
(SDGR) Investment Analysis - Stock Traders Daily
AI Pharma: 2 Paths to AI-Powered Drug Investment - MarketBeat
Schrödinger (NASDAQ:SDGR) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
KeyCorp Raises Schrödinger (NASDAQ:SDGR) Price Target to $27.00 - MarketBeat
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 25% Higher - Simply Wall St
Leerink Partnrs Reduces Earnings Estimates for Schrödinger - Defense World
KeyBanc raises Schrodinger stock target to $27, maintains Overweight - MSN
AI Stocks Are Soaring! Is Schrödinger, Inc. Leading the Charge? - Jomfruland.net
Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement - Insider Monkey
KeyBanc raises Schrodinger stock target to $27, maintains Overweight By Investing.com - Investing.com Canada
Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now - MSN
Top 10 Medical AI Stocks on Wall Street’s Radar - Insider Monkey
Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last? - Yahoo Finance
Investors Purchase Large Volume of Call Options on Schrödinger (NASDAQ:SDGR) - MarketBeat
Schrödinger Target of Unusually Large Options Trading (NASDAQ:SDGR) - Defense World
Schrodinger stock soars; Hunterbrook positive as AI integration promises drug discovery advances - MSN
Schrödinger (NASDAQ:SDGR) Trading Up 8%What's Next? - MarketBeat
Schrödinger (NASDAQ:SDGR) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Schrödinger Target of Unusually High Options Trading (NASDAQ:SDGR) - MarketBeat
Schrödinger Awards RSU Grants to New Employees Under 2021 Inducement Plan - StockTitan
JPMorgan Chase & Co. Boosts Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Avanza Fonder AB Acquires New Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Objective long/short (SDGR) Report - Stock Traders Daily
Schrödinger receives regulatory approval for Novartis collaboration - MSN
Harbor Capital Advisors Inc. Reduces Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Goldman Sachs maintains Schrodinger stock at Neutral By Investing.com - Investing.com Canada
Goldman Sachs maintains Schrodinger stock at Neutral - Investing.com India
GAMMA Investing LLC Has $54,000 Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger Secures $150M Novartis Deal, Advances Three Clinical Programs for 2025 - StockTitan
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
(SDGR) Technical Pivots with Risk Controls - Stock Traders Daily
Companies Like Schrödinger (NASDAQ:SDGR) Are In A Position To Invest In Growth - Simply Wall St
Principal Financial Group Inc. Lowers Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger (NASDAQ:SDGR) Shares Up 3.4%What's Next? - MarketBeat
Geode Capital Management LLC Grows Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger (NASDAQ:SDGR) Shares Down 6.7%Time to Sell? - MarketBeat
Barclays PLC Increases Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.65%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):